<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Labcorp Completes Acquisition of Select Assets of BioReference Health&#x27;s Innovative Oncology and Related Clinical Testing Services Businesses â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Labcorp Completes Acquisition of Select Assets of BioReference Health&#x27;s Innovative Oncology and Related Clinical Testing Services Businesses</h2>
    <div class="badge">2025-09-15T12:30:00+00:00</div>
    <ul>
      <li>The company&#x27;s nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than 75% of the new drugs and therapeutic products approved in 2024 by the FDA, and perform more than 700 mill</li>
<li>We intend to utilize a portion of the proceeds to fund our recently expanded share repurchase authorization.&quot; BioReference Health&#x27;s continuing operations include its core clinical testing operations in the New York and N</li>
<li>15, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc.</li>
<li>The purchase price for the transaction is up to $225 million, including $192.5 million that was paid at closing and up to $32.5 million in an earnout based on performance.</li>
<li>and MIAMI, Sept.</li>
<li>Piper Sandler &amp; Co.</li>
<li>Learn more about us at www.labcorp.com</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Labcorp%20Completes%20Acquisition%20of%20Select%20Assets%20of%20BioReference%20Health%27s%20Innovative%20Oncology%20and%20Related%20Clinical%20Testing%20Services%20Businesses%0A%E2%80%A2%20The%20company%27s%20nearly%2070%2C000%20employees%20serve%20clients%20in%20approximately%20100%20countries%2C%20provided%20support%20for%20more%20than%2075%25%20of%20the%20new%20drugs%20and%20therapeutic%20products%20approved%20in%202024%20by%20the%20FDA%2C%20and%20perform%20more%20than%20700%20mill%0A%E2%80%A2%20We%20intend%20to%20utilize%20a%20portion%20of%20the%20proceeds%20to%20fund%20our%20recently%20expanded%20share%20repurchase%20authorization.%22%20BioReference%20Health%27s%20continuing%20operations%20include%20its%20core%20clinical%20testing%20operations%20in%20the%20New%20York%20and%20N%0A%E2%80%A2%2015%2C%202025%20%2FPRNewswire%2F%20--%20Labcorp%20%28NYSE%3A%20LH%29%2C%20a%20global%20leader%20of%20innovative%20and%20comprehensive%20laboratory%20services%2C%20and%20OPKO%20Health%2C%20Inc.%0A%E2%80%A2%20The%20purchase%20price%20for%20the%20transaction%20is%20up%20to%20%24225%20million%2C%20including%20%24192.5%20million%20that%20was%20paid%20at%20closing%20and%20up%20to%20%2432.5%20million%20in%20an%20earnout%20based%20on%20performance.%0A%E2%80%A2%20and%20MIAMI%2C%20Sept.%0A%E2%80%A2%20Piper%20Sandler%20%26%20Co.%0A%E2%80%A2%20Learn%20more%20about%20us%20at%20www.labcorp.com&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Flabcorp-completes-acquisition-of-select-assets-of-bioreference-health-s-innovati%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/labcorp-completes-acquisition-select-assets-123000533.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>